View of SEMAGLUTIDE AND TIRZEPATIDE IN THE TREATMENT OF OBESITY: BENEFITS, RISKS, AND CLINICAL PERSPECTIVES OF GLP-1 RECEPTOR AGONISTS

Return to Issue Details SEMAGLUTIDE AND TIRZEPATIDE IN THE TREATMENT OF OBESITY: BENEFITS, RISKS, AND CLINICAL PERSPECTIVES OF GLP-1 RECEPTOR AGONISTS Download Download PDF